Indexed logomarkindexed.vc

Poseida Therapeutics

Closed

Genentech

San Diego, United States · Founded 2014

Biotech
Healthcare
Headquarters
San Diego
Founded
2014
Website
poseida.com

About

Poseida Therapeutics developed differentiated allogeneic cell therapies and genetic medicines intended to address cancers and rare diseases. Its pipeline included investigational allogeneic CAR-T therapies for solid tumors and hematologic cancers alongside in vivo genetic medicines for populations with high unmet need. The company based its approach on proprietary platforms including piggyBac DNA delivery, Cas-CLOVER gene editing, Booster Molecule, nanoparticle delivery, and in-house cell-therapy manufacturing before Roche acquired it in early 2025.

Summary

Poseida Therapeutics is a Biotech company based in San Diego, United States, founded in 2014. Investors include Roche.

LinkedInX (Twitter)

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

AcquisitionAcquisition by RocheNov 2024

Sign up to see all 2 rounds

IPO through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Roche

Lead

1 round

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth Equity·$5.1B·Aug 2022
IVI-RMA

IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...

Valencia, Spain5001–10000Biotech, Healthcare
Private Equity·$3.3B·Apr 2022
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series A·$3.0B·Jan 2022
inVentiv HealthAcquired

inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...

Burlington, United States5001–10000Biotech, Healthcare
Private Equity·$3.0B·May 2017
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private Equity·$3.0B·Jan 2004
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate Round·$2.8B·Jan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Poseida Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/poseida-therapeutics"><img src="https://indexed.vc/api/badge/company/poseida-therapeutics" alt="Poseida Therapeutics on Indexed.vc" width="260" height="76" /></a>